BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting

The management of advanced-stage melanoma is clinically challenging, mainly because of its resistance to the currently available therapies. Therefore, it is important to develop alternative therapeutic strategies. The sigma-2 receptor (S2R) is overexpressed in proliferating tumor cells and represent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorbi, Claudia, Belluti, Silvia, Atene, Claudio Giacinto, Marocchi, Federica, Linciano, Pasquale, Roy, Neena, Paradiso, Elia, Casarini, Livio, Ronsisvalle, Simone, Zanocco-Marani, Tommaso, Brasili, Livio, Lanfrancone, Luisa, Imbriano, Carol, Di Rocco, Giulia, Franchini, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253401/
https://www.ncbi.nlm.nih.gov/pubmed/37298633
http://dx.doi.org/10.3390/ijms24119684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253401/
https://www.ncbi.nlm.nih.gov/pubmed/37298633
http://dx.doi.org/10.3390/ijms24119684

Ejemplares similares